THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS
Publication
, Conference
Tunks, R; Clowse, M; Brancazio, L; Barker, P
Published in: Journal of the American College of Cardiology
March 2012
Duke Scholars
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2012
Volume
59
Issue
13
Start / End Page
E765 / E765
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tunks, R., Clowse, M., Brancazio, L., & Barker, P. (2012). THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS. In Journal of the American College of Cardiology (Vol. 59, pp. E765–E765). Elsevier BV. https://doi.org/10.1016/s0735-1097(12)60766-9
Tunks, Robert, Megan Clowse, Leo Brancazio, and Piers Barker. “THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS.” In Journal of the American College of Cardiology, 59:E765–E765. Elsevier BV, 2012. https://doi.org/10.1016/s0735-1097(12)60766-9.
Tunks R, Clowse M, Brancazio L, Barker P. THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS. In: Journal of the American College of Cardiology. Elsevier BV; 2012. p. E765–E765.
Tunks, Robert, et al. “THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS.” Journal of the American College of Cardiology, vol. 59, no. 13, Elsevier BV, 2012, pp. E765–E765. Crossref, doi:10.1016/s0735-1097(12)60766-9.
Tunks R, Clowse M, Brancazio L, Barker P. THE ROLE OF ANTI-RO/SSA ANTIBODY LEVEL IN CONGENITAL HEART BLOCK AND POSSIBLE BENEFIT OF MATERNAL THERAPY WITH ANTI-INFLAMMATORY AGENTS. Journal of the American College of Cardiology. Elsevier BV; 2012. p. E765–E765.
Published In
Journal of the American College of Cardiology
DOI
ISSN
0735-1097
Publication Date
March 2012
Volume
59
Issue
13
Start / End Page
E765 / E765
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology